Seattle startup HDT Bio lands $1.8M U.S. Army grant to develop nasal spray against viruses Seattle startup HDT Bio will develop a nasal spray designed to counteract a wide range of respiratory viruses with a… Read More
Seattle’s HDT Bio to start U.S. clinical trials of its COVID-19 vaccine candidate An experimental COVID-19 vaccine in development by Seattle-based HDT Bio will enter early-stage clinical trials in the U.S., the company… Read More
